SPX4,233.27+26.00 0.62%
DIA334.91+1.20 0.36%
IXIC12,894.74+114.83 0.90%

--Goldman Sachs Downgrades Teladoc to Neutral From Buy, Lowers Price Target to $36 From $55, Share Drop 22% Premarket

--Goldman Sachs Downgrades Teladoc to Neutral From Buy, Lowers Price Target to $36 From $55, Share Drop 22% Premarket

MT Newswires · 07/28/2022 04:29

Please log in to view news